Global Influenza Vaccines Market Growth 2020-2025
The report requires updating with new data and is sent in 48 hours after order is placed.
According to this study, over the next five years the Influenza Vaccines market will register a 4.9%% CAGR in terms of revenue, the global market size will reach $ 3752.1 million by 2025, from $ 3099.1 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Influenza Vaccines business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Influenza Vaccines market by product type, application, key manufacturers and key regions and countries.
This study specially analyses the impact of Covid-19 outbreak on the Influenza Vaccines, covering the supply chain analysis, impact assessment to the Influenza Vaccines market size growth rate in several scenarios, and the measures to be undertaken by Influenza Vaccines companies in response to the COVID-19 epidemic.
Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Research objectives
According to this study, over the next five years the Influenza Vaccines market will register a 4.9%% CAGR in terms of revenue, the global market size will reach $ 3752.1 million by 2025, from $ 3099.1 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Influenza Vaccines business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Influenza Vaccines market by product type, application, key manufacturers and key regions and countries.
This study specially analyses the impact of Covid-19 outbreak on the Influenza Vaccines, covering the supply chain analysis, impact assessment to the Influenza Vaccines market size growth rate in several scenarios, and the measures to be undertaken by Influenza Vaccines companies in response to the COVID-19 epidemic.
Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
- Trivalent Flu Vaccines
- Quadrivalent Flu Vaccines
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
- Adults
- Pediatrics
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- AstraZeneca
- Green Cross
- CSL
- Sanofi
- Altimmune
- GlaxoSmithKline
- FOLIA BIOTECH
- BionVax
- Genentech
- FluGen
- UNM Pharma
- Vaxart
- Vaccitech
- Medicago
- Shijiazhuang Yiling Pharmaceutical
- Novavax
- Visterra
- SK Chemicals
- Moderna Therapeutics
- Vaxine Pty
Research objectives
- To study and analyze the global Influenza Vaccines consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
- To understand the structure of Influenza Vaccines market by identifying its various subsegments.
- Focuses on the key global Influenza Vaccines manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
- To analyze the Influenza Vaccines with respect to individual growth trends, future prospects, and their contribution to the total market.
- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
- To project the consumption of Influenza Vaccines submarkets, with respect to key regions (along with their respective key countries).
- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
- To strategically profile the key players and comprehensively analyze their growth strategies.
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Influenza Vaccines Consumption 2015-2025
2.1.2 Influenza Vaccines Consumption CAGR by Region
2.2 Influenza Vaccines Segment by Type
2.2.1 Trivalent Flu Vaccines
2.2.2 Quadrivalent Flu Vaccines
2.3 Influenza Vaccines Consumption by Type
2.3.1 Global Influenza Vaccines Consumption Market Share by Type (2015-2020)
2.3.2 Global Influenza Vaccines Revenue and Market Share by Type (2015-2020)
2.3.3 Global Influenza Vaccines Sale Price by Type (2015-2020)
2.4 Influenza Vaccines Segment by Application
2.4.1 Adults
2.4.2 Pediatrics
2.5 Influenza Vaccines Consumption by Application
2.5.1 Global Influenza Vaccines Consumption Market Share by Type (2015-2020)
2.5.2 Global Influenza Vaccines Value and Market Share by Type (2015-2020)
2.5.3 Global Influenza Vaccines Sale Price by Type (2015-2020)
3 GLOBAL INFLUENZA VACCINES BY COMPANY
3.1 Global Influenza Vaccines Sales Market Share by Company
3.1.1 Global Influenza Vaccines Sales by Company (2018-2020)
3.1.2 Global Influenza Vaccines Sales Market Share by Company (2018-2020)
3.2 Global Influenza Vaccines Revenue Market Share by Company
3.2.1 Global Influenza Vaccines Revenue by Company (2018-2020)
3.2.2 Global Influenza Vaccines Revenue Market Share by Company (2018-2020)
3.3 Global Influenza Vaccines Sale Price by Company
3.4 Global Influenza Vaccines Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Influenza Vaccines Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Influenza Vaccines Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 INFLUENZA VACCINES BY REGIONS
4.1 Influenza Vaccines by Regions
4.2 Americas Influenza Vaccines Consumption Growth
4.3 APAC Influenza Vaccines Consumption Growth
4.4 Europe Influenza Vaccines Consumption Growth
4.5 Middle East & Africa Influenza Vaccines Consumption Growth
5 AMERICAS
5.1 Americas Influenza Vaccines Consumption by Countries
5.1.1 Americas Influenza Vaccines Consumption by Countries (2015-2020)
5.1.2 Americas Influenza Vaccines Value by Countries (2015-2020)
5.2 Americas Influenza Vaccines Consumption by Type
5.3 Americas Influenza Vaccines Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Influenza Vaccines Consumption by Regions
6.1.1 APAC Influenza Vaccines Consumption by Regions (2015-2020)
6.1.2 APAC Influenza Vaccines Value by Regions (2015-2020)
6.2 APAC Influenza Vaccines Consumption by Type
6.3 APAC Influenza Vaccines Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 EUROPE
7.1 Europe Influenza Vaccines by Countries
7.1.1 Europe Influenza Vaccines Consumption by Countries (2015-2020)
7.1.2 Europe Influenza Vaccines Value by Countries (2015-2020)
7.2 Europe Influenza Vaccines Consumption by Type
7.3 Europe Influenza Vaccines Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Influenza Vaccines by Countries
8.1.1 Middle East & Africa Influenza Vaccines Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Influenza Vaccines Value by Countries (2015-2020)
8.2 Middle East & Africa Influenza Vaccines Consumption by Type
8.3 Middle East & Africa Influenza Vaccines Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 MARKETING, DISTRIBUTORS AND CUSTOMER
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Influenza Vaccines Distributors
10.3 Influenza Vaccines Customer
11 GLOBAL INFLUENZA VACCINES MARKET FORECAST
11.1 Global Influenza Vaccines Consumption Forecast (2021-2025)
11.2 Global Influenza Vaccines Forecast by Regions
11.2.1 Global Influenza Vaccines Forecast by Regions (2021-2025)
11.2.2 Global Influenza Vaccines Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast byRegions
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Influenza Vaccines Forecast by Type
11.8 Global Influenza Vaccines Forecast by Application
12 KEY PLAYERS ANALYSIS
12.1 AstraZeneca
12.1.1 Company Information
12.1.2 Influenza Vaccines Product Offered
12.1.3 AstraZeneca Influenza Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 AstraZeneca Latest Developments
12.2 Green Cross
12.2.1 Company Information
12.2.2 Influenza Vaccines Product Offered
12.2.3 Green Cross Influenza Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Green Cross Latest Developments
12.3 CSL
12.3.1 Company Information
12.3.2 Influenza Vaccines Product Offered
12.3.3 CSL Influenza Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 CSL Latest Developments
12.4 Sanofi
12.4.1 Company Information
12.4.2 Influenza Vaccines Product Offered
12.4.3 Sanofi Influenza Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Sanofi Latest Developments
12.5 Altimmune
12.5.1 Company Information
12.5.2 Influenza Vaccines Product Offered
12.5.3 Altimmune Influenza Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Altimmune Latest Developments
12.6 GlaxoSmithKline
12.6.1 Company Information
12.6.2 Influenza Vaccines Product Offered
12.6.3 GlaxoSmithKline Influenza Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 GlaxoSmithKline Latest Developments
12.7 FOLIA BIOTECH
12.7.1 Company Information
12.7.2 Influenza Vaccines Product Offered
12.7.3 FOLIA BIOTECH Influenza Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 FOLIA BIOTECH Latest Developments
12.8 BionVax
12.8.1 Company Information
12.8.2 Influenza Vaccines Product Offered
12.8.3 BionVax Influenza Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 BionVax Latest Developments
12.9 Genentech
12.9.1 Company Information
12.9.2 Influenza Vaccines Product Offered
12.9.3 Genentech Influenza Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 Genentech Latest Developments
12.10 FluGen
12.10.1 Company Information
12.10.2 Influenza Vaccines Product Offered
12.10.3 FluGen Influenza Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 FluGen Latest Developments
12.11 UNM Pharma
12.11.1 Company Information
12.11.2 Influenza Vaccines Product Offered
12.11.3 UNM Pharma Influenza Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.11.4 Main Business Overview
12.11.5 UNM Pharma Latest Developments
12.12 Vaxart
12.12.1 Company Information
12.12.2 Influenza Vaccines Product Offered
12.12.3 Vaxart Influenza Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.12.4 Main Business Overview
12.12.5 Vaxart Latest Developments
12.13 Vaccitech
12.13.1 Company Information
12.13.2 Influenza Vaccines Product Offered
12.13.3 Vaccitech Influenza Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.13.4 Main Business Overview
12.13.5 Vaccitech Latest Developments
12.14 Medicago
12.14.1 Company Information
12.14.2 Influenza Vaccines Product Offered
12.14.3 Medicago Influenza Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.14.4 Main Business Overview
12.14.5 Medicago Latest Developments
12.15 Shijiazhuang Yiling Pharmaceutical
12.15.1 Company Information
12.15.2 Influenza Vaccines Product Offered
12.15.3 Shijiazhuang Yiling Pharmaceutical Influenza Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.15.4 Main Business Overview
12.15.5 Shijiazhuang Yiling Pharmaceutical Latest Developments
12.16 Novavax
12.16.1 Company Information
12.16.2 Influenza Vaccines Product Offered
12.16.3 Novavax Influenza Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.16.4 Main Business Overview
12.16.5 Novavax Latest Developments
12.17 Visterra
12.17.1 Company Information
12.17.2 Influenza Vaccines Product Offered
12.17.3 Visterra Influenza Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.17.4 Main Business Overview
12.17.5 Visterra Latest Developments
12.18 SK Chemicals
12.18.1 Company Information
12.18.2 Influenza Vaccines Product Offered
12.18.3 SK Chemicals Influenza Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.18.4 Main Business Overview
12.18.5 SK Chemicals Latest Developments
12.19 Moderna Therapeutics
12.19.1 Company Information
12.19.2 Influenza Vaccines Product Offered
12.19.3 Moderna Therapeutics Influenza Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.19.4 Main Business Overview
12.19.5 Moderna Therapeutics Latest Developments
12.20 Vaxine Pty
12.20.1 Company Information
12.20.2 Influenza Vaccines Product Offered
12.20.3 Vaxine Pty Influenza Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.20.4 Main Business Overview
12.20.5 Vaxine Pty Latest Developments
13 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Influenza Vaccines Consumption 2015-2025
2.1.2 Influenza Vaccines Consumption CAGR by Region
2.2 Influenza Vaccines Segment by Type
2.2.1 Trivalent Flu Vaccines
2.2.2 Quadrivalent Flu Vaccines
2.3 Influenza Vaccines Consumption by Type
2.3.1 Global Influenza Vaccines Consumption Market Share by Type (2015-2020)
2.3.2 Global Influenza Vaccines Revenue and Market Share by Type (2015-2020)
2.3.3 Global Influenza Vaccines Sale Price by Type (2015-2020)
2.4 Influenza Vaccines Segment by Application
2.4.1 Adults
2.4.2 Pediatrics
2.5 Influenza Vaccines Consumption by Application
2.5.1 Global Influenza Vaccines Consumption Market Share by Type (2015-2020)
2.5.2 Global Influenza Vaccines Value and Market Share by Type (2015-2020)
2.5.3 Global Influenza Vaccines Sale Price by Type (2015-2020)
3 GLOBAL INFLUENZA VACCINES BY COMPANY
3.1 Global Influenza Vaccines Sales Market Share by Company
3.1.1 Global Influenza Vaccines Sales by Company (2018-2020)
3.1.2 Global Influenza Vaccines Sales Market Share by Company (2018-2020)
3.2 Global Influenza Vaccines Revenue Market Share by Company
3.2.1 Global Influenza Vaccines Revenue by Company (2018-2020)
3.2.2 Global Influenza Vaccines Revenue Market Share by Company (2018-2020)
3.3 Global Influenza Vaccines Sale Price by Company
3.4 Global Influenza Vaccines Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Influenza Vaccines Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Influenza Vaccines Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 INFLUENZA VACCINES BY REGIONS
4.1 Influenza Vaccines by Regions
4.2 Americas Influenza Vaccines Consumption Growth
4.3 APAC Influenza Vaccines Consumption Growth
4.4 Europe Influenza Vaccines Consumption Growth
4.5 Middle East & Africa Influenza Vaccines Consumption Growth
5 AMERICAS
5.1 Americas Influenza Vaccines Consumption by Countries
5.1.1 Americas Influenza Vaccines Consumption by Countries (2015-2020)
5.1.2 Americas Influenza Vaccines Value by Countries (2015-2020)
5.2 Americas Influenza Vaccines Consumption by Type
5.3 Americas Influenza Vaccines Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Influenza Vaccines Consumption by Regions
6.1.1 APAC Influenza Vaccines Consumption by Regions (2015-2020)
6.1.2 APAC Influenza Vaccines Value by Regions (2015-2020)
6.2 APAC Influenza Vaccines Consumption by Type
6.3 APAC Influenza Vaccines Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 EUROPE
7.1 Europe Influenza Vaccines by Countries
7.1.1 Europe Influenza Vaccines Consumption by Countries (2015-2020)
7.1.2 Europe Influenza Vaccines Value by Countries (2015-2020)
7.2 Europe Influenza Vaccines Consumption by Type
7.3 Europe Influenza Vaccines Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Influenza Vaccines by Countries
8.1.1 Middle East & Africa Influenza Vaccines Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Influenza Vaccines Value by Countries (2015-2020)
8.2 Middle East & Africa Influenza Vaccines Consumption by Type
8.3 Middle East & Africa Influenza Vaccines Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 MARKETING, DISTRIBUTORS AND CUSTOMER
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Influenza Vaccines Distributors
10.3 Influenza Vaccines Customer
11 GLOBAL INFLUENZA VACCINES MARKET FORECAST
11.1 Global Influenza Vaccines Consumption Forecast (2021-2025)
11.2 Global Influenza Vaccines Forecast by Regions
11.2.1 Global Influenza Vaccines Forecast by Regions (2021-2025)
11.2.2 Global Influenza Vaccines Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast byRegions
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Influenza Vaccines Forecast by Type
11.8 Global Influenza Vaccines Forecast by Application
12 KEY PLAYERS ANALYSIS
12.1 AstraZeneca
12.1.1 Company Information
12.1.2 Influenza Vaccines Product Offered
12.1.3 AstraZeneca Influenza Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 AstraZeneca Latest Developments
12.2 Green Cross
12.2.1 Company Information
12.2.2 Influenza Vaccines Product Offered
12.2.3 Green Cross Influenza Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Green Cross Latest Developments
12.3 CSL
12.3.1 Company Information
12.3.2 Influenza Vaccines Product Offered
12.3.3 CSL Influenza Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 CSL Latest Developments
12.4 Sanofi
12.4.1 Company Information
12.4.2 Influenza Vaccines Product Offered
12.4.3 Sanofi Influenza Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Sanofi Latest Developments
12.5 Altimmune
12.5.1 Company Information
12.5.2 Influenza Vaccines Product Offered
12.5.3 Altimmune Influenza Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Altimmune Latest Developments
12.6 GlaxoSmithKline
12.6.1 Company Information
12.6.2 Influenza Vaccines Product Offered
12.6.3 GlaxoSmithKline Influenza Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 GlaxoSmithKline Latest Developments
12.7 FOLIA BIOTECH
12.7.1 Company Information
12.7.2 Influenza Vaccines Product Offered
12.7.3 FOLIA BIOTECH Influenza Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 FOLIA BIOTECH Latest Developments
12.8 BionVax
12.8.1 Company Information
12.8.2 Influenza Vaccines Product Offered
12.8.3 BionVax Influenza Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 BionVax Latest Developments
12.9 Genentech
12.9.1 Company Information
12.9.2 Influenza Vaccines Product Offered
12.9.3 Genentech Influenza Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 Genentech Latest Developments
12.10 FluGen
12.10.1 Company Information
12.10.2 Influenza Vaccines Product Offered
12.10.3 FluGen Influenza Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 FluGen Latest Developments
12.11 UNM Pharma
12.11.1 Company Information
12.11.2 Influenza Vaccines Product Offered
12.11.3 UNM Pharma Influenza Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.11.4 Main Business Overview
12.11.5 UNM Pharma Latest Developments
12.12 Vaxart
12.12.1 Company Information
12.12.2 Influenza Vaccines Product Offered
12.12.3 Vaxart Influenza Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.12.4 Main Business Overview
12.12.5 Vaxart Latest Developments
12.13 Vaccitech
12.13.1 Company Information
12.13.2 Influenza Vaccines Product Offered
12.13.3 Vaccitech Influenza Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.13.4 Main Business Overview
12.13.5 Vaccitech Latest Developments
12.14 Medicago
12.14.1 Company Information
12.14.2 Influenza Vaccines Product Offered
12.14.3 Medicago Influenza Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.14.4 Main Business Overview
12.14.5 Medicago Latest Developments
12.15 Shijiazhuang Yiling Pharmaceutical
12.15.1 Company Information
12.15.2 Influenza Vaccines Product Offered
12.15.3 Shijiazhuang Yiling Pharmaceutical Influenza Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.15.4 Main Business Overview
12.15.5 Shijiazhuang Yiling Pharmaceutical Latest Developments
12.16 Novavax
12.16.1 Company Information
12.16.2 Influenza Vaccines Product Offered
12.16.3 Novavax Influenza Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.16.4 Main Business Overview
12.16.5 Novavax Latest Developments
12.17 Visterra
12.17.1 Company Information
12.17.2 Influenza Vaccines Product Offered
12.17.3 Visterra Influenza Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.17.4 Main Business Overview
12.17.5 Visterra Latest Developments
12.18 SK Chemicals
12.18.1 Company Information
12.18.2 Influenza Vaccines Product Offered
12.18.3 SK Chemicals Influenza Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.18.4 Main Business Overview
12.18.5 SK Chemicals Latest Developments
12.19 Moderna Therapeutics
12.19.1 Company Information
12.19.2 Influenza Vaccines Product Offered
12.19.3 Moderna Therapeutics Influenza Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.19.4 Main Business Overview
12.19.5 Moderna Therapeutics Latest Developments
12.20 Vaxine Pty
12.20.1 Company Information
12.20.2 Influenza Vaccines Product Offered
12.20.3 Vaxine Pty Influenza Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.20.4 Main Business Overview
12.20.5 Vaxine Pty Latest Developments
13 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Research Methodology
Table 2. Data Source
Table 3. Influenza Vaccines Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Trivalent Flu Vaccines
Table 5. Major Players of Quadrivalent Flu Vaccines
Table 6. Global Consumption Sales by Type (2015-2020)
Table 7. Global Influenza Vaccines Consumption Market Share by Type (2015-2020)
Table 8. Global Influenza Vaccines Revenue by Type (2015-2020) ($ million)
Table 9. Global Influenza Vaccines Value Market Share by Type (2015-2020) ($ Millions)
Table 10. Global Influenza Vaccines Sale Price by Type (2015-2020)
Table 11. Global Consumption Sales by Application (2015-2020)
Table 12. Global Influenza Vaccines Consumption Market Share by Application (2015-2020)
Table 13. Global Influenza Vaccines Value by Application (2015-2020)
Table 14. Global Influenza Vaccines Value Market Share by Application (2015-2020)
Table 15. Global Influenza Vaccines Sale Price by Application (2015-2020)
Table 16. Global Influenza Vaccines Sales by Company (2017-2019) (K Units)
Table 17. Global Influenza Vaccines Sales Market Share by Company (2017-2019)
Table 18. Global Influenza Vaccines Revenue by Company (2017-2019) ($ Millions)
Table 19. Global Influenza Vaccines Revenue Market Share by Company (2017-2019)
Table 20. Global Influenza Vaccines Sale Price by Company (2017-2019)
Table 21. Global Influenza Vaccines Manufacturing Base Distribution and Sales Area by Manufacturers
Table 22. Players Influenza Vaccines Products Offered
Table 23. Influenza Vaccines Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 24. Global Influenza Vaccines Consumption by Regions 2015-2020 (K Units)
Table 25. Global Influenza Vaccines Consumption Market Share by Regions 2015-2020
Table 26. Global Influenza Vaccines Value by Regions 2015-2020 ($ Millions)
Table 27. Global Influenza Vaccines Value Market Share by Regions 2015-2020
Table 28. Americas Influenza Vaccines Consumption by Countries (2015-2020) (K Units)
Table 29. Americas Influenza Vaccines Consumption Market Share by Countries (2015-2020)
Table 30. Americas Influenza Vaccines Value by Countries (2015-2020) ($ Millions)
Table 31. Americas Influenza Vaccines Value Market Share by Countries (2015-2020)
Table 32. Americas Influenza Vaccines Consumption by Type (2015-2020) (K Units)
Table 33. Americas Influenza Vaccines Consumption Market Share by Type (2015-2020)
Table 34. Americas Influenza Vaccines Consumption by Application (2015-2020) (K Units)
Table 35. Americas Influenza Vaccines Consumption Market Share by Application (2015-2020)
Table 36. APAC Influenza Vaccines Consumption by Regions (2015-2020) (K Units)
Table 37. APAC Influenza Vaccines Consumption Market Share by Regions (2015-2020)
Table 38. APAC Influenza Vaccines Value by Regions (2015-2020) ($ Millions)
Table 39. APAC Influenza Vaccines Value Market Share by Regions (2015-2020)
Table 40. APAC Influenza Vaccines Consumption by Type (2015-2020) (K Units)
Table 41. APAC Influenza Vaccines Consumption Market Share by Type (2015-2020)
Table 42. APAC Influenza Vaccines Consumption by Application (2015-2020) (K Units)
Table 43. APAC Influenza Vaccines Consumption Market Share by Application (2015-2020)
Table 44. Europe Influenza Vaccines Consumption by Countries (2015-2020) (K Units)
Table 45. Europe Influenza Vaccines Consumption Market Share by Countries (2015-2020)
Table 46. Europe Influenza Vaccines Value by Countries (2015-2020) ($ Millions)
Table 47. Europe Influenza Vaccines Value Market Share by Countries (2015-2020)
Table 48. Europe Influenza Vaccines Consumption by Type (2015-2020) (K Units)
Table 49. Europe Influenza Vaccines Consumption Market Share by Type (2015-2020)
Table 50. Europe Influenza Vaccines Consumption by Application (2015-2020) (K Units)
Table 51. Europe Influenza Vaccines Consumption Market Share by Application (2015-2020)
Table 52. Middle East & Africa Influenza Vaccines Consumption by Countries (2015-2020) (K Units)
Table 53. Middle East & Africa Influenza Vaccines Consumption Market Share by Countries (2015-2020)
Table 54. Middle East & Africa Influenza Vaccines Value by Countries (2015-2020) ($ Millions)
Table 55. Middle East & Africa Influenza Vaccines Value Market Share by Countries (2015-2020)
Table 56. Middle East & Africa Influenza Vaccines Consumption by Type (2015-2020) (K Units)
Table 57. Middle East & Africa Influenza Vaccines Consumption Market Share by Type (2015-2020)
Table 58. Middle East & Africa Influenza Vaccines Consumption by Application (2015-2020) (K Units)
Table 59. Middle East & Africa Influenza Vaccines Consumption Market Share by Application (2015-2020)
Table 60. Influenza Vaccines Distributors List
Table 61. Influenza Vaccines Customer List
Table 62. Global Influenza Vaccines Consumption Forecast by Countries (2021-2025) (K Units)
Table 63. Global Influenza Vaccines Consumption Market Forecast by Regions
Table 64. Global Influenza Vaccines Value Forecast by Countries (2021-2025) ($ Millions)
Table 65. Global Influenza Vaccines Value Market Share Forecast by Regions
Table 66. Global Influenza Vaccines Consumption Forecast by Type (2021-2025) (K Units)
Table 67. Global Influenza Vaccines Consumption Market Share Forecast by Type (2021-2025)
Table 68. Global Influenza Vaccines Value Forecast by Type (2021-2025) ($ Millions)
Table 69. Global Influenza Vaccines Value Market Share Forecast by Type (2021-2025)
Table 70. Global Influenza Vaccines Consumption Forecast by Application (2021-2025) (K Units)
Table 71. Global Influenza Vaccines Consumption Market Share Forecast by Application (2021-2025)
Table 72. Global Influenza Vaccines Value Forecast by Application (2021-2025) ($ Millions)
Table 73. Global Influenza Vaccines Value Market Share Forecast by Application (2021-2025)
Table 74. AstraZeneca Product Offered
Table 75. AstraZeneca Influenza Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 76. AstraZeneca Main Business
Table 77. AstraZeneca Latest Developments
Table 78. AstraZeneca Basic Information, Company Total Revenue (in $ million), Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 79. Green Cross Product Offered
Table 80. Green Cross Influenza Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 81. Green Cross Main Business
Table 82. Green Cross Latest Developments
Table 83. Green Cross Basic Information, Company Total Revenue (in $ million), Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 84. CSL Product Offered
Table 85. CSL Influenza Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 86. CSL Main Business
Table 87. CSL Latest Developments
Table 88. CSL Basic Information, Company Total Revenue (in $ million), Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 89. Sanofi Product Offered
Table 90. Sanofi Influenza Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 91. Sanofi Main Business
Table 92. Sanofi Latest Developments
Table 93. Sanofi Basic Information, Company Total Revenue (in $ million), Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 94. Altimmune Product Offered
Table 95. Altimmune Influenza Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 96. Altimmune Main Business
Table 97. Altimmune Latest Developments
Table 98. Altimmune Basic Information, Company Total Revenue (in $ million), Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 99. GlaxoSmithKline Product Offered
Table 100. GlaxoSmithKline Influenza Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 101. GlaxoSmithKline Main Business
Table 102. GlaxoSmithKline Latest Developments
Table 103. GlaxoSmithKline Basic Information, Company Total Revenue (in $ million), Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 104. FOLIA BIOTECH Product Offered
Table 105. FOLIA BIOTECH Basic Information, Company Total Revenue (in $ million), Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 106. FOLIA BIOTECH Main Business
Table 107. FOLIA BIOTECH Latest Developments
Table 108. FOLIA BIOTECH Influenza Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 109. BionVax Product Offered
Table 110. BionVax Influenza Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 111. BionVax Main Business
Table 112. BionVax Latest Developments
Table 113. BionVax Basic Information, Company Total Revenue (in $ million), Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 114. Genentech Product Offered
Table 115. Genentech Influenza Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 116. Genentech Main Business
Table 117. Genentech Latest Developments
Table 118. Genentech Basic Information, Company Total Revenue (in $ million), Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 119. FluGen Product Offered
Table 120. FluGen Influenza Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 121. FluGen Main Business
Table 122. FluGen Latest Developments
Table 123. FluGen Basic Information, Company Total Revenue (in $ million), Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 124. UNM Pharma Product Offered
Table 125. UNM Pharma Influenza Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 126. UNM Pharma Main Business
Table 127. UNM Pharma Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 128. UNM Pharma Latest Developments
Table 129. Vaxart Product Offered
Table 130. Vaxart Influenza Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 131. Vaxart Main Business
Table 132. Vaxart Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 133. Vaxart Latest Developments
Table 134. Vaccitech Product Offered
Table 135. Vaccitech Influenza Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 136. Vaccitech Main Business
Table 137. Vaccitech Latest Developments
Table 138. Vaccitech Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 139. Medicago Product Offered
Table 140. Medicago Influenza Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 141. Medicago Main Business
Table 142. Medicago Latest Developments
Table 143. Medicago Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 144. Shijiazhuang Yiling Pharmaceutical Product Offered
Table 145. Shijiazhuang Yiling Pharmaceutical Influenza Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 146. Shijiazhuang Yiling Pharmaceutical Main Business
Table 147. Shijiazhuang Yiling Pharmaceutical Latest Developments
Table 148. Shijiazhuang Yiling Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 149. Novavax Product Offered
Table 150. Novavax Influenza Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 151. Novavax Main Business
Table 152. Novavax Latest Developments
Table 153. Novavax Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 154. Visterra Product Offered
Table 155. Visterra Influenza Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 156. Visterra Main Business
Table 157. Visterra Latest Developments
Table 158. Visterra Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 159. SK Chemicals Product Offered
Table 160. SK Chemicals Influenza Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 161. SK Chemicals Main Business
Table 162. SK Chemicals Latest Developments
Table 163. SK Chemicals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 164. Moderna Therapeutics Product Offered
Table 165. Moderna Therapeutics Influenza Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 166. Moderna Therapeutics Main Business
Table 167. Moderna Therapeutics Latest Developments
Table 168. Moderna Therapeutics Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 169. Vaxine Pty Product Offered
Table 170. Vaxine Pty Influenza Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 171. Vaxine Pty Main Business
Table 172. Vaxine Pty Latest Developments
Table 173. Vaxine Pty Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 1. Research Methodology
Table 2. Data Source
Table 3. Influenza Vaccines Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Trivalent Flu Vaccines
Table 5. Major Players of Quadrivalent Flu Vaccines
Table 6. Global Consumption Sales by Type (2015-2020)
Table 7. Global Influenza Vaccines Consumption Market Share by Type (2015-2020)
Table 8. Global Influenza Vaccines Revenue by Type (2015-2020) ($ million)
Table 9. Global Influenza Vaccines Value Market Share by Type (2015-2020) ($ Millions)
Table 10. Global Influenza Vaccines Sale Price by Type (2015-2020)
Table 11. Global Consumption Sales by Application (2015-2020)
Table 12. Global Influenza Vaccines Consumption Market Share by Application (2015-2020)
Table 13. Global Influenza Vaccines Value by Application (2015-2020)
Table 14. Global Influenza Vaccines Value Market Share by Application (2015-2020)
Table 15. Global Influenza Vaccines Sale Price by Application (2015-2020)
Table 16. Global Influenza Vaccines Sales by Company (2017-2019) (K Units)
Table 17. Global Influenza Vaccines Sales Market Share by Company (2017-2019)
Table 18. Global Influenza Vaccines Revenue by Company (2017-2019) ($ Millions)
Table 19. Global Influenza Vaccines Revenue Market Share by Company (2017-2019)
Table 20. Global Influenza Vaccines Sale Price by Company (2017-2019)
Table 21. Global Influenza Vaccines Manufacturing Base Distribution and Sales Area by Manufacturers
Table 22. Players Influenza Vaccines Products Offered
Table 23. Influenza Vaccines Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 24. Global Influenza Vaccines Consumption by Regions 2015-2020 (K Units)
Table 25. Global Influenza Vaccines Consumption Market Share by Regions 2015-2020
Table 26. Global Influenza Vaccines Value by Regions 2015-2020 ($ Millions)
Table 27. Global Influenza Vaccines Value Market Share by Regions 2015-2020
Table 28. Americas Influenza Vaccines Consumption by Countries (2015-2020) (K Units)
Table 29. Americas Influenza Vaccines Consumption Market Share by Countries (2015-2020)
Table 30. Americas Influenza Vaccines Value by Countries (2015-2020) ($ Millions)
Table 31. Americas Influenza Vaccines Value Market Share by Countries (2015-2020)
Table 32. Americas Influenza Vaccines Consumption by Type (2015-2020) (K Units)
Table 33. Americas Influenza Vaccines Consumption Market Share by Type (2015-2020)
Table 34. Americas Influenza Vaccines Consumption by Application (2015-2020) (K Units)
Table 35. Americas Influenza Vaccines Consumption Market Share by Application (2015-2020)
Table 36. APAC Influenza Vaccines Consumption by Regions (2015-2020) (K Units)
Table 37. APAC Influenza Vaccines Consumption Market Share by Regions (2015-2020)
Table 38. APAC Influenza Vaccines Value by Regions (2015-2020) ($ Millions)
Table 39. APAC Influenza Vaccines Value Market Share by Regions (2015-2020)
Table 40. APAC Influenza Vaccines Consumption by Type (2015-2020) (K Units)
Table 41. APAC Influenza Vaccines Consumption Market Share by Type (2015-2020)
Table 42. APAC Influenza Vaccines Consumption by Application (2015-2020) (K Units)
Table 43. APAC Influenza Vaccines Consumption Market Share by Application (2015-2020)
Table 44. Europe Influenza Vaccines Consumption by Countries (2015-2020) (K Units)
Table 45. Europe Influenza Vaccines Consumption Market Share by Countries (2015-2020)
Table 46. Europe Influenza Vaccines Value by Countries (2015-2020) ($ Millions)
Table 47. Europe Influenza Vaccines Value Market Share by Countries (2015-2020)
Table 48. Europe Influenza Vaccines Consumption by Type (2015-2020) (K Units)
Table 49. Europe Influenza Vaccines Consumption Market Share by Type (2015-2020)
Table 50. Europe Influenza Vaccines Consumption by Application (2015-2020) (K Units)
Table 51. Europe Influenza Vaccines Consumption Market Share by Application (2015-2020)
Table 52. Middle East & Africa Influenza Vaccines Consumption by Countries (2015-2020) (K Units)
Table 53. Middle East & Africa Influenza Vaccines Consumption Market Share by Countries (2015-2020)
Table 54. Middle East & Africa Influenza Vaccines Value by Countries (2015-2020) ($ Millions)
Table 55. Middle East & Africa Influenza Vaccines Value Market Share by Countries (2015-2020)
Table 56. Middle East & Africa Influenza Vaccines Consumption by Type (2015-2020) (K Units)
Table 57. Middle East & Africa Influenza Vaccines Consumption Market Share by Type (2015-2020)
Table 58. Middle East & Africa Influenza Vaccines Consumption by Application (2015-2020) (K Units)
Table 59. Middle East & Africa Influenza Vaccines Consumption Market Share by Application (2015-2020)
Table 60. Influenza Vaccines Distributors List
Table 61. Influenza Vaccines Customer List
Table 62. Global Influenza Vaccines Consumption Forecast by Countries (2021-2025) (K Units)
Table 63. Global Influenza Vaccines Consumption Market Forecast by Regions
Table 64. Global Influenza Vaccines Value Forecast by Countries (2021-2025) ($ Millions)
Table 65. Global Influenza Vaccines Value Market Share Forecast by Regions
Table 66. Global Influenza Vaccines Consumption Forecast by Type (2021-2025) (K Units)
Table 67. Global Influenza Vaccines Consumption Market Share Forecast by Type (2021-2025)
Table 68. Global Influenza Vaccines Value Forecast by Type (2021-2025) ($ Millions)
Table 69. Global Influenza Vaccines Value Market Share Forecast by Type (2021-2025)
Table 70. Global Influenza Vaccines Consumption Forecast by Application (2021-2025) (K Units)
Table 71. Global Influenza Vaccines Consumption Market Share Forecast by Application (2021-2025)
Table 72. Global Influenza Vaccines Value Forecast by Application (2021-2025) ($ Millions)
Table 73. Global Influenza Vaccines Value Market Share Forecast by Application (2021-2025)
Table 74. AstraZeneca Product Offered
Table 75. AstraZeneca Influenza Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 76. AstraZeneca Main Business
Table 77. AstraZeneca Latest Developments
Table 78. AstraZeneca Basic Information, Company Total Revenue (in $ million), Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 79. Green Cross Product Offered
Table 80. Green Cross Influenza Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 81. Green Cross Main Business
Table 82. Green Cross Latest Developments
Table 83. Green Cross Basic Information, Company Total Revenue (in $ million), Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 84. CSL Product Offered
Table 85. CSL Influenza Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 86. CSL Main Business
Table 87. CSL Latest Developments
Table 88. CSL Basic Information, Company Total Revenue (in $ million), Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 89. Sanofi Product Offered
Table 90. Sanofi Influenza Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 91. Sanofi Main Business
Table 92. Sanofi Latest Developments
Table 93. Sanofi Basic Information, Company Total Revenue (in $ million), Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 94. Altimmune Product Offered
Table 95. Altimmune Influenza Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 96. Altimmune Main Business
Table 97. Altimmune Latest Developments
Table 98. Altimmune Basic Information, Company Total Revenue (in $ million), Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 99. GlaxoSmithKline Product Offered
Table 100. GlaxoSmithKline Influenza Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 101. GlaxoSmithKline Main Business
Table 102. GlaxoSmithKline Latest Developments
Table 103. GlaxoSmithKline Basic Information, Company Total Revenue (in $ million), Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 104. FOLIA BIOTECH Product Offered
Table 105. FOLIA BIOTECH Basic Information, Company Total Revenue (in $ million), Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 106. FOLIA BIOTECH Main Business
Table 107. FOLIA BIOTECH Latest Developments
Table 108. FOLIA BIOTECH Influenza Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 109. BionVax Product Offered
Table 110. BionVax Influenza Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 111. BionVax Main Business
Table 112. BionVax Latest Developments
Table 113. BionVax Basic Information, Company Total Revenue (in $ million), Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 114. Genentech Product Offered
Table 115. Genentech Influenza Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 116. Genentech Main Business
Table 117. Genentech Latest Developments
Table 118. Genentech Basic Information, Company Total Revenue (in $ million), Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 119. FluGen Product Offered
Table 120. FluGen Influenza Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 121. FluGen Main Business
Table 122. FluGen Latest Developments
Table 123. FluGen Basic Information, Company Total Revenue (in $ million), Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 124. UNM Pharma Product Offered
Table 125. UNM Pharma Influenza Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 126. UNM Pharma Main Business
Table 127. UNM Pharma Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 128. UNM Pharma Latest Developments
Table 129. Vaxart Product Offered
Table 130. Vaxart Influenza Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 131. Vaxart Main Business
Table 132. Vaxart Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 133. Vaxart Latest Developments
Table 134. Vaccitech Product Offered
Table 135. Vaccitech Influenza Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 136. Vaccitech Main Business
Table 137. Vaccitech Latest Developments
Table 138. Vaccitech Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 139. Medicago Product Offered
Table 140. Medicago Influenza Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 141. Medicago Main Business
Table 142. Medicago Latest Developments
Table 143. Medicago Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 144. Shijiazhuang Yiling Pharmaceutical Product Offered
Table 145. Shijiazhuang Yiling Pharmaceutical Influenza Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 146. Shijiazhuang Yiling Pharmaceutical Main Business
Table 147. Shijiazhuang Yiling Pharmaceutical Latest Developments
Table 148. Shijiazhuang Yiling Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 149. Novavax Product Offered
Table 150. Novavax Influenza Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 151. Novavax Main Business
Table 152. Novavax Latest Developments
Table 153. Novavax Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 154. Visterra Product Offered
Table 155. Visterra Influenza Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 156. Visterra Main Business
Table 157. Visterra Latest Developments
Table 158. Visterra Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 159. SK Chemicals Product Offered
Table 160. SK Chemicals Influenza Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 161. SK Chemicals Main Business
Table 162. SK Chemicals Latest Developments
Table 163. SK Chemicals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 164. Moderna Therapeutics Product Offered
Table 165. Moderna Therapeutics Influenza Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 166. Moderna Therapeutics Main Business
Table 167. Moderna Therapeutics Latest Developments
Table 168. Moderna Therapeutics Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 169. Vaxine Pty Product Offered
Table 170. Vaxine Pty Influenza Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 171. Vaxine Pty Main Business
Table 172. Vaxine Pty Latest Developments
Table 173. Vaxine Pty Basic Information, Manufacturing Base, Sales Area and Its Competitors
LIST OF FIGURES
Figure 1. Picture of Influenza Vaccines
Figure 2. Influenza Vaccines Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Influenza Vaccines Consumption Growth Rate 2015-2025 (K Units)
Figure 5. Global Influenza Vaccines Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of Trivalent Flu Vaccines
Figure 7. Product Picture of Quadrivalent Flu Vaccines
Figure 8. Global Influenza Vaccines Consumption Market Share by Type (2015-2020)
Figure 9. Global Influenza Vaccines Value Market Share by Type (2015-2020)
Figure 10. Influenza Vaccines Consumed in Adults
Figure 11. Global Influenza Vaccines Market: Adults (2015-2020) (K Units)
Figure 12. Global Influenza Vaccines Market: Adults (2015-2020) ($ Millions)
Figure 13. Influenza Vaccines Consumed in Pediatrics
Figure 14. Global Influenza Vaccines Market: Pediatrics (2015-2020) (K Units)
Figure 15. Global Influenza Vaccines Market: Pediatrics (2015-2020) ($ Millions)
Figure 16. Global Influenza Vaccines Consumption Market Share by Application (2015-2020)
Figure 17. Global Influenza Vaccines Value Market Share by Application (2015-2020)
Figure 18. Global Influenza Vaccines Sales Market Share by Company in 2017
Figure 19. Global Influenza Vaccines Sales Market Share by Company in 2019
Figure 20. Global Influenza Vaccines Revenue Market Share by Company in 2017
Figure 21. Global Influenza Vaccines Revenue Market Share by Company in 2019
Figure 22. Global Influenza Vaccines Sale Price by Company in 2019
Figure 23. Global Influenza Vaccines Consumption Market Share by Regions 2015-2020
Figure 24. Global Influenza Vaccines Value Market Share by Regions 2015-2020
Figure 25. Americas Influenza Vaccines Consumption 2015-2020 (K Units)
Figure 26. Americas Influenza Vaccines Value 2015-2020 ($ Millions)
Figure 27. APAC Influenza Vaccines Consumption 2015-2020 (K Units)
Figure 28. APAC Influenza Vaccines Value 2015-2020 ($ Millions)
Figure 29. Europe Influenza Vaccines Consumption 2015-2020 (K Units)
Figure 30. Europe Influenza Vaccines Value 2015-2020 ($ Millions)
Figure 31. Middle East & Africa Influenza Vaccines Consumption 2015-2020 (K Units)
Figure 32. Middle East & Africa Influenza Vaccines Value 2015-2020 ($ Millions)
Figure 33. Americas Influenza Vaccines Consumption Market Share by Countries in 2019
Figure 34. Americas Influenza Vaccines Value Market Share by Countries in 2019
Figure 35. Americas Influenza Vaccines Consumption Market Share by Type in 2019
Figure 36. Americas Influenza Vaccines Consumption Market Share by Application in 2019
Figure 37. United States Influenza Vaccines Consumption Growth 2015-2020 (K Units)
Figure 38. United States Influenza Vaccines Value Growth 2015-2020 ($ Millions)
Figure 39. Canada Influenza Vaccines Consumption Growth 2015-2020 (K Units)
Figure 40. Canada Influenza Vaccines Value Growth 2015-2020 ($ Millions)
Figure 41. Mexico Influenza Vaccines Consumption Growth 2015-2020 (K Units)
Figure 42. Mexico Influenza Vaccines Value Growth 2015-2020 ($ Millions)
Figure 43. APAC Influenza Vaccines Consumption Market Share by Countries in 2019
Figure 44. APAC Influenza Vaccines Value Market Share by Regions in 2019
Figure 45. APAC Influenza Vaccines Consumption Market Share by Type in 2019
Figure 46. APAC Influenza Vaccines Consumption Market Share by Application in 2019
Figure 47. China Influenza Vaccines Consumption Growth 2015-2020 (K Units)
Figure 48. China Influenza Vaccines Value Growth 2015-2020 ($ Millions)
Figure 49. Japan Influenza Vaccines Consumption Growth 2015-2020 (K Units)
Figure 50. Japan Influenza Vaccines Value Growth 2015-2020 ($ Millions)
Figure 51. Korea Influenza Vaccines Consumption Growth 2015-2020 (K Units)
Figure 52. Korea Influenza Vaccines Value Growth 2015-2020 ($ Millions)
Figure 53. Southeast Asia Influenza Vaccines Consumption Growth 2015-2020 (K Units)
Figure 54. Southeast Asia Influenza Vaccines Value Growth 2015-2020 ($ Millions)
Figure 55. India Influenza Vaccines Consumption Growth 2015-2020 (K Units)
Figure 56. India Influenza Vaccines Value Growth 2015-2020 ($ Millions)
Figure 57. Australia Influenza Vaccines Consumption Growth 2015-2020 (K Units)
Figure 58. Australia Influenza Vaccines Value Growth 2015-2020 ($ Millions)
Figure 59. Europe Influenza Vaccines Consumption Market Share by Countries in 2019
Figure 60. Europe Influenza Vaccines Value Market Share by Countries in 2019
Figure 61. Europe Influenza Vaccines Consumption Market Share by Type in 2019
Figure 62. Europe Influenza Vaccines Consumption Market Share by Application in 2019
Figure 63. Germany Influenza Vaccines Consumption Growth 2015-2020 (K Units)
Figure 64. Germany Influenza Vaccines Value Growth 2015-2020 ($ Millions)
Figure 65. France Influenza Vaccines Consumption Growth 2015-2020 (K Units)
Figure 66. France Influenza Vaccines Value Growth 2015-2020 ($ Millions)
Figure 67. UK Influenza Vaccines Consumption Growth 2015-2020 (K Units)
Figure 68. UK Influenza Vaccines Value Growth 2015-2020 ($ Millions)
Figure 69. Italy Influenza Vaccines Consumption Growth 2015-2020 (K Units)
Figure 70. Italy Influenza Vaccines Value Growth 2015-2020 ($ Millions)
Figure 71. Russia Influenza Vaccines Consumption Growth 2015-2020 (K Units)
Figure 72. Russia Influenza Vaccines Value Growth 2015-2020 ($ Millions)
Figure 73. Middle East & Africa Influenza Vaccines Consumption Market Share by Countries in 2019
Figure 74. Middle East & Africa Influenza Vaccines Value Market Share by Countries in 2019
Figure 75. Middle East & Africa Influenza Vaccines Consumption Market Share by Type in 2019
Figure 76. Middle East & Africa Influenza Vaccines Consumption Market Share by Application in 2019
Figure 77. Egypt Influenza Vaccines Consumption Growth 2015-2020 (K Units)
Figure 78. Egypt Influenza Vaccines Value Growth 2015-2020 ($ Millions)
Figure 79. South Africa Influenza Vaccines Consumption Growth 2015-2020 (K Units)
Figure 80. South Africa Influenza Vaccines Value Growth 2015-2020 ($ Millions)
Figure 81. Israel Influenza Vaccines Consumption Growth 2015-2020 (K Units)
Figure 82. Israel Influenza Vaccines Value Growth 2015-2020 ($ Millions)
Figure 83. Turkey Influenza Vaccines Consumption Growth 2015-2020 (K Units)
Figure 84. Turkey Influenza Vaccines Value Growth 2015-2020 ($ Millions)
Figure 85. GCC Countries Influenza Vaccines Consumption Growth 2015-2020 (K Units)
Figure 86. GCC Countries Influenza Vaccines Value Growth 2015-2020 ($ Millions)
Figure 87. Global Influenza Vaccines Consumption Growth Rate Forecast (2021-2025) (K Units)
Figure 88. Global Influenza Vaccines Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 89. Americas Influenza Vaccines Consumption 2021-2025 (K Units)
Figure 90. Americas Influenza Vaccines Value 2021-2025 ($ Millions)
Figure 91. APAC Influenza Vaccines Consumption 2021-2025 (K Units)
Figure 92. APAC Influenza Vaccines Value 2021-2025 ($ Millions)
Figure 93. Europe Influenza Vaccines Consumption 2021-2025 (K Units)
Figure 94. Europe Influenza Vaccines Value 2021-2025 ($ Millions)
Figure 95. Middle East & Africa Influenza Vaccines Consumption 2021-2025 (K Units)
Figure 96. Middle East & Africa Influenza Vaccines Value 2021-2025 ($ Millions)
Figure 97. United States Influenza Vaccines Consumption 2021-2025 (K Units)
Figure 98. United States Influenza Vaccines Value 2021-2025 ($ Millions)
Figure 99. Canada Influenza Vaccines Consumption 2021-2025 (K Units)
Figure 100. Canada Influenza Vaccines Value 2021-2025 ($ Millions)
Figure 101. Mexico Influenza Vaccines Consumption 2021-2025 (K Units)
Figure 102. Mexico Influenza Vaccines Value 2021-2025 ($ Millions)
Figure 103. Brazil Influenza Vaccines Consumption 2021-2025 (K Units)
Figure 104. Brazil Influenza Vaccines Value 2021-2025 ($ Millions)
Figure 105. China Influenza Vaccines Consumption 2021-2025 (K Units)
Figure 106. China Influenza Vaccines Value 2021-2025 ($ Millions)
Figure 107. Japan Influenza Vaccines Consumption 2021-2025 (K Units)
Figure 108. Japan Influenza Vaccines Value 2021-2025 ($ Millions)
Figure 109. Korea Influenza Vaccines Consumption 2021-2025 (K Units)
Figure 110. Korea Influenza Vaccines Value 2021-2025 ($ Millions)
Figure 111. Southeast Asia Influenza Vaccines Consumption 2021-2025 (K Units)
Figure 112. Southeast Asia Influenza Vaccines Value 2021-2025 ($ Millions)
Figure 113. India Influenza Vaccines Consumption 2021-2025 (K Units)
Figure 114. India Influenza Vaccines Value 2021-2025 ($ Millions)
Figure 115. Australia Influenza Vaccines Consumption 2021-2025 (K Units)
Figure 116. Australia Influenza Vaccines Value 2021-2025 ($ Millions)
Figure 117. Germany Influenza Vaccines Consumption 2021-2025 (K Units)
Figure 118. Germany Influenza Vaccines Value 2021-2025 ($ Millions)
Figure 119. France Influenza Vaccines Consumption 2021-2025 (K Units)
Figure 120. France Influenza Vaccines Value 2021-2025 ($ Millions)
Figure 121. UK Influenza Vaccines Consumption 2021-2025 (K Units)
Figure 122. UK Influenza Vaccines Value 2021-2025 ($ Millions)
Figure 123. Italy Influenza Vaccines Consumption 2021-2025 (K Units)
Figure 124. Italy Influenza Vaccines Value 2021-2025 ($ Millions)
Figure 125. Russia Influenza Vaccines Consumption 2021-2025 (K Units)
Figure 126. Russia Influenza Vaccines Value 2021-2025 ($ Millions)
Figure 127. Spain Influenza Vaccines Consumption 2021-2025 (K Units)
Figure 128. Spain Influenza Vaccines Value 2021-2025 ($ Millions)
Figure 129. Egypt Influenza Vaccines Consumption 2021-2025 (K Units)
Figure 130. Egypt Influenza Vaccines Value 2021-2025 ($ Millions)
Figure 131. South Africa Influenza Vaccines Consumption 2021-2025 (K Units)
Figure 132. South Africa Influenza Vaccines Value 2021-2025 ($ Millions)
Figure 133. Israel Influenza Vaccines Consumption 2021-2025 (K Units)
Figure 134. Israel Influenza Vaccines Value 2021-2025 ($ Millions)
Figure 135. Turkey Influenza Vaccines Consumption 2021-2025 (K Units)
Figure 136. Turkey Influenza Vaccines Value 2021-2025 ($ Millions)
Figure 137. GCC Countries Influenza Vaccines Consumption 2021-2025 (K Units)
Figure 138. GCC Countries Influenza Vaccines Value 2021-2025 ($ Millions)
Figure 139. AstraZeneca Influenza Vaccines Market Share (2018-2020)
Figure 140. Green Cross Influenza Vaccines Market Share (2018-2020)
Figure 141. CSL Influenza Vaccines Market Share (2018-2020)
Figure 142. Sanofi Influenza Vaccines Market Share (2018-2020)
Figure 143. Altimmune Influenza Vaccines Market Share (2018-2020)
Figure 144. GlaxoSmithKline Influenza Vaccines Market Share (2018-2020)
Figure 145. FOLIA BIOTECH Influenza Vaccines Market Share (2018-2020)
Figure 146. BionVax Influenza Vaccines Market Share (2018-2020)
Figure 147. Genentech Influenza Vaccines Market Share (2018-2020)
Figure 148. FluGen Influenza Vaccines Market Share (2018-2020)
Figure 149. UNM Pharma Influenza Vaccines Market Share (2018-2020)
Figure 150. Vaxart Influenza Vaccines Market Share (2018-2020)
Figure 151. Vaccitech Influenza Vaccines Market Share (2018-2020)
Figure 152. Medicago Influenza Vaccines Market Share (2018-2020)
Figure 153. Shijiazhuang Yiling Pharmaceutical Influenza Vaccines Market Share (2018-2020)
Figure 154. Novavax Influenza Vaccines Market Share (2018-2020)
Figure 155. Visterra Influenza Vaccines Market Share (2018-2020)
Figure 156. SK Chemicals Influenza Vaccines Market Share (2018-2020)
Figure 157. Moderna Therapeutics Influenza Vaccines Market Share (2018-2020)
Figure 158. Vaxine Pty Influenza Vaccines Market Share (2018-2020)
Figure 1. Picture of Influenza Vaccines
Figure 2. Influenza Vaccines Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Influenza Vaccines Consumption Growth Rate 2015-2025 (K Units)
Figure 5. Global Influenza Vaccines Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of Trivalent Flu Vaccines
Figure 7. Product Picture of Quadrivalent Flu Vaccines
Figure 8. Global Influenza Vaccines Consumption Market Share by Type (2015-2020)
Figure 9. Global Influenza Vaccines Value Market Share by Type (2015-2020)
Figure 10. Influenza Vaccines Consumed in Adults
Figure 11. Global Influenza Vaccines Market: Adults (2015-2020) (K Units)
Figure 12. Global Influenza Vaccines Market: Adults (2015-2020) ($ Millions)
Figure 13. Influenza Vaccines Consumed in Pediatrics
Figure 14. Global Influenza Vaccines Market: Pediatrics (2015-2020) (K Units)
Figure 15. Global Influenza Vaccines Market: Pediatrics (2015-2020) ($ Millions)
Figure 16. Global Influenza Vaccines Consumption Market Share by Application (2015-2020)
Figure 17. Global Influenza Vaccines Value Market Share by Application (2015-2020)
Figure 18. Global Influenza Vaccines Sales Market Share by Company in 2017
Figure 19. Global Influenza Vaccines Sales Market Share by Company in 2019
Figure 20. Global Influenza Vaccines Revenue Market Share by Company in 2017
Figure 21. Global Influenza Vaccines Revenue Market Share by Company in 2019
Figure 22. Global Influenza Vaccines Sale Price by Company in 2019
Figure 23. Global Influenza Vaccines Consumption Market Share by Regions 2015-2020
Figure 24. Global Influenza Vaccines Value Market Share by Regions 2015-2020
Figure 25. Americas Influenza Vaccines Consumption 2015-2020 (K Units)
Figure 26. Americas Influenza Vaccines Value 2015-2020 ($ Millions)
Figure 27. APAC Influenza Vaccines Consumption 2015-2020 (K Units)
Figure 28. APAC Influenza Vaccines Value 2015-2020 ($ Millions)
Figure 29. Europe Influenza Vaccines Consumption 2015-2020 (K Units)
Figure 30. Europe Influenza Vaccines Value 2015-2020 ($ Millions)
Figure 31. Middle East & Africa Influenza Vaccines Consumption 2015-2020 (K Units)
Figure 32. Middle East & Africa Influenza Vaccines Value 2015-2020 ($ Millions)
Figure 33. Americas Influenza Vaccines Consumption Market Share by Countries in 2019
Figure 34. Americas Influenza Vaccines Value Market Share by Countries in 2019
Figure 35. Americas Influenza Vaccines Consumption Market Share by Type in 2019
Figure 36. Americas Influenza Vaccines Consumption Market Share by Application in 2019
Figure 37. United States Influenza Vaccines Consumption Growth 2015-2020 (K Units)
Figure 38. United States Influenza Vaccines Value Growth 2015-2020 ($ Millions)
Figure 39. Canada Influenza Vaccines Consumption Growth 2015-2020 (K Units)
Figure 40. Canada Influenza Vaccines Value Growth 2015-2020 ($ Millions)
Figure 41. Mexico Influenza Vaccines Consumption Growth 2015-2020 (K Units)
Figure 42. Mexico Influenza Vaccines Value Growth 2015-2020 ($ Millions)
Figure 43. APAC Influenza Vaccines Consumption Market Share by Countries in 2019
Figure 44. APAC Influenza Vaccines Value Market Share by Regions in 2019
Figure 45. APAC Influenza Vaccines Consumption Market Share by Type in 2019
Figure 46. APAC Influenza Vaccines Consumption Market Share by Application in 2019
Figure 47. China Influenza Vaccines Consumption Growth 2015-2020 (K Units)
Figure 48. China Influenza Vaccines Value Growth 2015-2020 ($ Millions)
Figure 49. Japan Influenza Vaccines Consumption Growth 2015-2020 (K Units)
Figure 50. Japan Influenza Vaccines Value Growth 2015-2020 ($ Millions)
Figure 51. Korea Influenza Vaccines Consumption Growth 2015-2020 (K Units)
Figure 52. Korea Influenza Vaccines Value Growth 2015-2020 ($ Millions)
Figure 53. Southeast Asia Influenza Vaccines Consumption Growth 2015-2020 (K Units)
Figure 54. Southeast Asia Influenza Vaccines Value Growth 2015-2020 ($ Millions)
Figure 55. India Influenza Vaccines Consumption Growth 2015-2020 (K Units)
Figure 56. India Influenza Vaccines Value Growth 2015-2020 ($ Millions)
Figure 57. Australia Influenza Vaccines Consumption Growth 2015-2020 (K Units)
Figure 58. Australia Influenza Vaccines Value Growth 2015-2020 ($ Millions)
Figure 59. Europe Influenza Vaccines Consumption Market Share by Countries in 2019
Figure 60. Europe Influenza Vaccines Value Market Share by Countries in 2019
Figure 61. Europe Influenza Vaccines Consumption Market Share by Type in 2019
Figure 62. Europe Influenza Vaccines Consumption Market Share by Application in 2019
Figure 63. Germany Influenza Vaccines Consumption Growth 2015-2020 (K Units)
Figure 64. Germany Influenza Vaccines Value Growth 2015-2020 ($ Millions)
Figure 65. France Influenza Vaccines Consumption Growth 2015-2020 (K Units)
Figure 66. France Influenza Vaccines Value Growth 2015-2020 ($ Millions)
Figure 67. UK Influenza Vaccines Consumption Growth 2015-2020 (K Units)
Figure 68. UK Influenza Vaccines Value Growth 2015-2020 ($ Millions)
Figure 69. Italy Influenza Vaccines Consumption Growth 2015-2020 (K Units)
Figure 70. Italy Influenza Vaccines Value Growth 2015-2020 ($ Millions)
Figure 71. Russia Influenza Vaccines Consumption Growth 2015-2020 (K Units)
Figure 72. Russia Influenza Vaccines Value Growth 2015-2020 ($ Millions)
Figure 73. Middle East & Africa Influenza Vaccines Consumption Market Share by Countries in 2019
Figure 74. Middle East & Africa Influenza Vaccines Value Market Share by Countries in 2019
Figure 75. Middle East & Africa Influenza Vaccines Consumption Market Share by Type in 2019
Figure 76. Middle East & Africa Influenza Vaccines Consumption Market Share by Application in 2019
Figure 77. Egypt Influenza Vaccines Consumption Growth 2015-2020 (K Units)
Figure 78. Egypt Influenza Vaccines Value Growth 2015-2020 ($ Millions)
Figure 79. South Africa Influenza Vaccines Consumption Growth 2015-2020 (K Units)
Figure 80. South Africa Influenza Vaccines Value Growth 2015-2020 ($ Millions)
Figure 81. Israel Influenza Vaccines Consumption Growth 2015-2020 (K Units)
Figure 82. Israel Influenza Vaccines Value Growth 2015-2020 ($ Millions)
Figure 83. Turkey Influenza Vaccines Consumption Growth 2015-2020 (K Units)
Figure 84. Turkey Influenza Vaccines Value Growth 2015-2020 ($ Millions)
Figure 85. GCC Countries Influenza Vaccines Consumption Growth 2015-2020 (K Units)
Figure 86. GCC Countries Influenza Vaccines Value Growth 2015-2020 ($ Millions)
Figure 87. Global Influenza Vaccines Consumption Growth Rate Forecast (2021-2025) (K Units)
Figure 88. Global Influenza Vaccines Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 89. Americas Influenza Vaccines Consumption 2021-2025 (K Units)
Figure 90. Americas Influenza Vaccines Value 2021-2025 ($ Millions)
Figure 91. APAC Influenza Vaccines Consumption 2021-2025 (K Units)
Figure 92. APAC Influenza Vaccines Value 2021-2025 ($ Millions)
Figure 93. Europe Influenza Vaccines Consumption 2021-2025 (K Units)
Figure 94. Europe Influenza Vaccines Value 2021-2025 ($ Millions)
Figure 95. Middle East & Africa Influenza Vaccines Consumption 2021-2025 (K Units)
Figure 96. Middle East & Africa Influenza Vaccines Value 2021-2025 ($ Millions)
Figure 97. United States Influenza Vaccines Consumption 2021-2025 (K Units)
Figure 98. United States Influenza Vaccines Value 2021-2025 ($ Millions)
Figure 99. Canada Influenza Vaccines Consumption 2021-2025 (K Units)
Figure 100. Canada Influenza Vaccines Value 2021-2025 ($ Millions)
Figure 101. Mexico Influenza Vaccines Consumption 2021-2025 (K Units)
Figure 102. Mexico Influenza Vaccines Value 2021-2025 ($ Millions)
Figure 103. Brazil Influenza Vaccines Consumption 2021-2025 (K Units)
Figure 104. Brazil Influenza Vaccines Value 2021-2025 ($ Millions)
Figure 105. China Influenza Vaccines Consumption 2021-2025 (K Units)
Figure 106. China Influenza Vaccines Value 2021-2025 ($ Millions)
Figure 107. Japan Influenza Vaccines Consumption 2021-2025 (K Units)
Figure 108. Japan Influenza Vaccines Value 2021-2025 ($ Millions)
Figure 109. Korea Influenza Vaccines Consumption 2021-2025 (K Units)
Figure 110. Korea Influenza Vaccines Value 2021-2025 ($ Millions)
Figure 111. Southeast Asia Influenza Vaccines Consumption 2021-2025 (K Units)
Figure 112. Southeast Asia Influenza Vaccines Value 2021-2025 ($ Millions)
Figure 113. India Influenza Vaccines Consumption 2021-2025 (K Units)
Figure 114. India Influenza Vaccines Value 2021-2025 ($ Millions)
Figure 115. Australia Influenza Vaccines Consumption 2021-2025 (K Units)
Figure 116. Australia Influenza Vaccines Value 2021-2025 ($ Millions)
Figure 117. Germany Influenza Vaccines Consumption 2021-2025 (K Units)
Figure 118. Germany Influenza Vaccines Value 2021-2025 ($ Millions)
Figure 119. France Influenza Vaccines Consumption 2021-2025 (K Units)
Figure 120. France Influenza Vaccines Value 2021-2025 ($ Millions)
Figure 121. UK Influenza Vaccines Consumption 2021-2025 (K Units)
Figure 122. UK Influenza Vaccines Value 2021-2025 ($ Millions)
Figure 123. Italy Influenza Vaccines Consumption 2021-2025 (K Units)
Figure 124. Italy Influenza Vaccines Value 2021-2025 ($ Millions)
Figure 125. Russia Influenza Vaccines Consumption 2021-2025 (K Units)
Figure 126. Russia Influenza Vaccines Value 2021-2025 ($ Millions)
Figure 127. Spain Influenza Vaccines Consumption 2021-2025 (K Units)
Figure 128. Spain Influenza Vaccines Value 2021-2025 ($ Millions)
Figure 129. Egypt Influenza Vaccines Consumption 2021-2025 (K Units)
Figure 130. Egypt Influenza Vaccines Value 2021-2025 ($ Millions)
Figure 131. South Africa Influenza Vaccines Consumption 2021-2025 (K Units)
Figure 132. South Africa Influenza Vaccines Value 2021-2025 ($ Millions)
Figure 133. Israel Influenza Vaccines Consumption 2021-2025 (K Units)
Figure 134. Israel Influenza Vaccines Value 2021-2025 ($ Millions)
Figure 135. Turkey Influenza Vaccines Consumption 2021-2025 (K Units)
Figure 136. Turkey Influenza Vaccines Value 2021-2025 ($ Millions)
Figure 137. GCC Countries Influenza Vaccines Consumption 2021-2025 (K Units)
Figure 138. GCC Countries Influenza Vaccines Value 2021-2025 ($ Millions)
Figure 139. AstraZeneca Influenza Vaccines Market Share (2018-2020)
Figure 140. Green Cross Influenza Vaccines Market Share (2018-2020)
Figure 141. CSL Influenza Vaccines Market Share (2018-2020)
Figure 142. Sanofi Influenza Vaccines Market Share (2018-2020)
Figure 143. Altimmune Influenza Vaccines Market Share (2018-2020)
Figure 144. GlaxoSmithKline Influenza Vaccines Market Share (2018-2020)
Figure 145. FOLIA BIOTECH Influenza Vaccines Market Share (2018-2020)
Figure 146. BionVax Influenza Vaccines Market Share (2018-2020)
Figure 147. Genentech Influenza Vaccines Market Share (2018-2020)
Figure 148. FluGen Influenza Vaccines Market Share (2018-2020)
Figure 149. UNM Pharma Influenza Vaccines Market Share (2018-2020)
Figure 150. Vaxart Influenza Vaccines Market Share (2018-2020)
Figure 151. Vaccitech Influenza Vaccines Market Share (2018-2020)
Figure 152. Medicago Influenza Vaccines Market Share (2018-2020)
Figure 153. Shijiazhuang Yiling Pharmaceutical Influenza Vaccines Market Share (2018-2020)
Figure 154. Novavax Influenza Vaccines Market Share (2018-2020)
Figure 155. Visterra Influenza Vaccines Market Share (2018-2020)
Figure 156. SK Chemicals Influenza Vaccines Market Share (2018-2020)
Figure 157. Moderna Therapeutics Influenza Vaccines Market Share (2018-2020)
Figure 158. Vaxine Pty Influenza Vaccines Market Share (2018-2020)
